Myeloma Patients Europe is a network of highly efficient, effective and sustainable myeloma patient organisations across Europe.
Our mission is to provide education, information and support to member groups and to advocate at European, national and local levels for the best possible research and equal access to the best possible treatment and care.
Find out more in our website http:// www.mpeurope.org
The current therapeutic approach of multiple myeloma has made significant strides towards in the last decade. New treatments and diagnosis criteria have obtained greater survival rates as well as a better quality of life for patients.
However, there are still significant differences in access to treatment and care which are a potential source of inequity and could mean some patients may live longer and with a better quality of life than others depending on the country the live in.
In this setting, Myeloma Patients Europe in close liaison with Avedis Donabedian Research Foundation has been working intensively during the last two years on the development of the European Atlas of Access to Myeloma Treatment to identify the variation of access to treatment in the European countries as well as its possible causes. All of this aiming to collaborate in the efforts to improve access to myeloma treatment in Europe.